We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 24th:
Callaway Golf Company : This sells golf-related products, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings jumping 23.5% over the last 60 days.
QuinStreet, Inc. (QNST - Free Report) : This internet performance marketing company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 12.3% over the last 60 days.
Cadence Design Systems, Inc. (CDNS - Free Report) : This electronic design automation software provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 3.7% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Growth Stocks to Buy for August 24th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 24th:
Callaway Golf Company : This sells golf-related products, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings jumping 23.5% over the last 60 days.
Callaway Golf Company Price and Consensus
Callaway Golf Company price-consensus-chart | Callaway Golf Company Quote
Callaway Golf has a PEG ratio of 0.91, compared with 1.23 for the industry. The company possesses a Growth Score of A.
Callaway Golf Company PEG Ratio (TTM)
Callaway Golf Company peg-ratio-ttm | Callaway Golf Company Quote
QuinStreet, Inc. (QNST - Free Report) : This internet performance marketing company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 12.3% over the last 60 days.
QuinStreet, Inc. Price and Consensus
QuinStreet, Inc. price-consensus-chart | QuinStreet, Inc. Quote
QuinStreet has a PEG ratio 0.92, compared with 1.32 for the industry. The company possesses a Growth Score of A.
QuinStreet, Inc. PEG Ratio (TTM)
QuinStreet, Inc. peg-ratio-ttm | QuinStreet, Inc. Quote
Cadence Design Systems, Inc. (CDNS - Free Report) : This electronic design automation software provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 3.7% over the last 60 days.
Cadence Design Systems, Inc. Price and Consensus
Cadence Design Systems, Inc. price-consensus-chart | Cadence Design Systems, Inc. Quote
Cadence Design has a PEG ratio of 2.26, compared with 13.42 for the industry. The company possesses a Growth Score of A.
Cadence Design Systems, Inc. PEG Ratio (TTM)
Cadence Design Systems, Inc. peg-ratio-ttm | Cadence Design Systems, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>